UK markets open in 9 minutes

ACADIA Pharmaceuticals Inc. (ACAD)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
16.71-0.39 (-2.28%)
At close: 04:00PM EDT
16.71 0.00 (0.00%)
After hours: 05:35PM EDT
Currency in USD
Earnings estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts19192020
Avg. Estimate0.050.190.641.26
Low estimate-0.080.110.30.79
High estimate0.170.270.972.16
Year ago EPS-0.270.01-0.370.64
Revenue estimateCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
No. of analysts18182020
Avg. Estimate208.36M241.81M967.32M1.09B
Low estimate201.3M235.9M940.7M993.2M
High estimate223.7M253M983.8M1.2B
Year ago sales118.46M157.81M726.44M967.32M
Sales growth (year/est)75.90%53.20%33.20%13.10%
Earnings history30/03/202329/06/202329/09/202330/12/2023
Est. EPS-0.21-0.08-0.430.3
Actual EPS-0.270.01-0.40.28
Difference-0.060.090.03-0.02
Surprise %-28.60%112.50%7.00%-6.70%
EPS trendCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Current estimate0.050.190.641.26
7 days ago0.050.190.641.26
30 days ago0.060.20.671.28
60 days ago0.10.230.781.46
90 days ago0.20.331.021.75
EPS revisionsCurrent qtr. (Mar 2024)Next qtr. (Jun 2024)Current year (2024)Next year (2025)
Up last 7 daysN/A1N/AN/A
Up last 30 days11N/AN/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 days2111
Growth estimatesACADIndustrySector(s)S&P 500
Current qtr.118.50%N/AN/AN/A
Next qtr.1,800.00%N/AN/AN/A
Current year273.00%N/AN/AN/A
Next year96.90%N/AN/AN/A
Next 5 years (per annum)-357.00%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A